The US Food and Drug Administration’s oversight of dietary supplement and other food and nutritional product manufacturing and marketing will be tested by Trump administration layoffs on whether the agency has sufficient staffing to ensure consumer access to safe products.
Layoffs At US FDA: Agency’s Food Programs Remain Effective, Or Product Safety Threatened?
Supplement industry trade groups and an attorney offer differing views of impact from layoffs imposed by White House’s “Department of Government Efficiency” reportedly numbering as many as 700. They agree layoffs, reported as some 700 across the agency with its food safety programs particularly hit, will affect FDA’s work, but not on whether it will be able to fulfill its responsibilities.

More from Leadership
More from HBW Insight
Chinese consumers are now routinely taking supplements for a variety of health reasons, helping to drive up sales of the Swisse Plus+ brand by 20% in 2024.
US FDA Commissioner nominee Martin Makary is being embraced by industry, and Senate Democrats, as a more traditional pick than other Trump Administration nominees, but the Make America Healthy Again agenda still is clearly coming to the agency.
FDA says “extension affords covered entities the additional time necessary to ensure complete coordination across the supply chain in order to fully implement the final rule’s requirements—ultimately providing FDA and consumers with greater transparency and food safety.”